Back to search

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study

Data up to Jan 2025

Published2002
Citations89
References7

Total Citations Per Year

Abstract

Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms… (2002) – Blood | Metascience Observatory Explorer